Welcome to the Amprion 2023 landing page! From here you can download through the links below or explore the rest of our website.

We are excited be exhibiting at MDS 2023
Booth #263

Poster# 253

Date: Monday, August 28, 2023

Time: 1:00pm-3:00pm CEST

Title:   Widespread Synuclein Pathology in Hyposmics precedes dopamine transporter deficit in PARS.

Poster #33

Date: Monday, August 28, 2023

Time: 1:00pm– 3:00pm CEST

Title:   A staged screening paradigm to identify people at rest of Parkinson’s disease in the Parkinson’s Progression Markers Initiative


AD/DLB Flyer

Misfolded α-synuclein (αSyn) aggregates (αSyn-seeds) in cerebrospinal fluid (CSF) are biomarkers for synucleinopathies

“Mov Disord. 2023”

The purpose of this study was to determine the sensitivity and specificity of α-synuclein seed amplification

“Ann Neurol. 2022”

Biomarkers for α-synucleinopathies that reflect underlying pathology are sorely needed to improve the accuracy of early diagnosis and identify subtypes based on molecular factors and thus accelerate clinical trials.

“Movement Disorders, June 2023”

Amprion Science Lab

Contact us to schedule a meeting


Amprion has some important news we need to share with you!

To improve patient access to the SYNTap® biomarker test (CSF), Amprion is reducing the self-pay price for tests with service dates on or after July 1, 2023.

Old self-pay price: $1500.00. New self-pay price: $995.00

Effective July 1, 2023, there is a New ABN (Advanced Beneficiary Notification) form for use when ordering the SYNTap® biomarker test (CSF) for patients on Medicare. Order Process

CPT/PLA – The SYNTap® test has been issued a dedicated PLA code to be used when billing: 0393U
We have applied to be a medicare provider and will soon be able to courtesy bill Medicare for your patients.